#USA #Washington #Radiation Therapy #ONCare Alliance #Klarity

Klarity and ONCare Alliance Forge Partnership

In a significant development for community oncology practices, Klarity has announced a vendor partnership with ONCare Alliance, marking an important step towards enhancing the quality of cancer treatment. This collaboration aims to provide ONCare clinics with access to Klarity’s comprehensive range of radiation therapy positioning and immobilization solutions, which play a crucial role in patient care.

Commitment to Excellence

Both organizations share a steadfast commitment to patient-centered care and their combined mission is geared towards delivering excellence in oncology treatment. The partnership emerges from ONCare Alliance's ongoing endeavor to evaluate vendors that can offer meaningful improvements in the quality and efficiency of cancer treatment.

Sean Perkins, co-chair of the Radiation Oncology Advanced Imaging Work Group at ONCare Alliance, emphasized the importance of strategic vendor partnerships in achieving operational efficiency while preserving the autonomy of local practices. Through their collaboration with Klarity, member practices are poised to benefit significantly from innovative technologies that streamline clinical workflows and improve patient outcomes.

Benefits Beyond Pricing

An essential player in this partnership is Clarion, a subsidiary of ONCare Alliance, which operates as an independent buying group. Clarion aims to unite community oncology practices, leveraging collective purchasing power to reduce costs on indispensable equipment, medical supplies, and services. This enables clinics to not only access high-quality resources but also preserves their independent decision-making regarding purchases.

With Klarity onboard as a partnered vendor, practices affiliated with ONCare Alliance will gain direct access to an extensive array of positioning products designed to improve cancer treatment delivery. The integration of educational resources for continuing education further underscores the partnership’s dedication to enhancing clinical practices and outcomes.

Best Practices and Community Engagement

Cheryl S. Turner, Ed.D., R.T., (R)(T), Chief Sales Officer of Klarity, expressed the company’s commitment to supporting ONCare Alliance’s mission. She stated, “Klarity is honored to support the mission of ONCare Alliance through the delivery of customized patient immobilization products, education on radiation therapy best practices, and meaningful community engagement.” This sentiment highlights the partnership’s focus on ensuring that patients receive optimal care throughout their cancer journey.

Collaborative Future

The partnership between Klarity and ONCare Alliance represents more than just an agreement; it symbolizes a concerted effort to advance the highest standards of care in oncology. Both organizations are leveraging their unique capabilities to enhance access to innovative solutions and facilitate an ecosystem where high-quality patient care thrives. As they work together, both Klarity and ONCare Alliance are determined to support their member practices while fostering a collaborative environment that promotes the latest developments in cancer treatments and practices across the country.

In conclusion, the implications of this vendor partnership stretch far beyond mere product access—it lays the groundwork for improved patient experiences, streamlined workflows, and the continuation of a robust support network tailored for oncology practices. As this partnership unfolds, it is poised to make a meaningful impact on cancer care delivery in community settings.